Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults

Title
Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 11, Issue 11, Pages 1519-1524
Publisher
Informa Healthcare
Online
2011-08-31
DOI
10.1517/14712598.2011.610788

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started